N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143236 |
| CAS No | NA |
| Mol.F. | C31H32N4O7S |
| Mol.Wt. | 604.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143237 |
| CAS No | NA |
| Mol.F. | C27H26N4O7S |
| Mol.Wt. | 550.59 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143238 |
| CAS No | NA |
| Mol.F. | C46H48N6O9S |
| Mol.Wt. | 860.98 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143239 |
| CAS No | NA |
| Mol.F. | C47H47N5O11S2 |
| Mol.Wt. | 922.04 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143240 |
| CAS No | NA |
| Mol.F. | C20H23ClN2O2 |
| Mol.Wt. | 358.9 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143241 |
| CAS No | NA |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143242 |
| CAS No | NA |
| Mol.F. | C20H23ClN2O2 |
| Mol.Wt. | 358.9 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143243 |
| CAS No | NA |
| Mol.F. | C14H12N2O4 |
| Mol.Wt. | 272.26 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143244 |
| CAS No | NA |
| Mol.F. | C14H11ClN2O2 |
| Mol.Wt. | 274.70 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143245 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O3 |
| Mol.Wt. | 315.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143246 |
| CAS No | NA |
| Mol.F. | C16H12ClN3O3 |
| Mol.Wt. | 329.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143247 |
| CAS No | NA |
| Mol.F. | C19H19FN2O4 |
| Mol.Wt. | 358.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143248 |
| CAS No | NA |
| Mol.F. | C21H24N2O5 |
| Mol.Wt. | 384.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143249 |
| CAS No | NA |
| Mol.F. | C20H22N2O5 |
| Mol.Wt. | 370.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143250 |
| CAS No | NA |
| Mol.F. | C19H19FN2O4 |
| Mol.Wt. | 358.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143251 |
| CAS No | NA |
| Mol.F. | C17H23ClN4O4 |
| Mol.Wt. | 382.85 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |